Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP2533776B2 - Topical skin - Google Patents
[go: Go Back, main page]

JP2533776B2 - Topical skin - Google Patents

Topical skin

Info

Publication number
JP2533776B2
JP2533776B2 JP11784087A JP11784087A JP2533776B2 JP 2533776 B2 JP2533776 B2 JP 2533776B2 JP 11784087 A JP11784087 A JP 11784087A JP 11784087 A JP11784087 A JP 11784087A JP 2533776 B2 JP2533776 B2 JP 2533776B2
Authority
JP
Japan
Prior art keywords
acid
salt
skin
present
external preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP11784087A
Other languages
Japanese (ja)
Other versions
JPS63284119A (en
Inventor
政雄 釈
敏夫 御器谷
久男 岩淵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Orbis Holdings Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Priority to JP11784087A priority Critical patent/JP2533776B2/en
Publication of JPS63284119A publication Critical patent/JPS63284119A/en
Application granted granted Critical
Publication of JP2533776B2 publication Critical patent/JP2533776B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明はイソフェルラ酸および(または)その塩と有
機酸および(または)その塩とを配合することにより、
優れた紫外線防御効果ならびに美白効果と、優れた品質
をもつ皮膚外用剤を提供するものである。
DETAILED DESCRIPTION OF THE INVENTION (Industrial field of application) The present invention provides a compound of isoferulic acid and / or a salt thereof with an organic acid and / or a salt thereof,
It is intended to provide a skin external preparation having an excellent UV protection effect, a whitening effect, and an excellent quality.

(従来技術および発明の解決しようとする問題点) 通常、太陽光線は日焼けを起すばかりでなく、その日
焼けのために皮膚の老化を促進することが知られてい
る。この太陽光線を防ぐためにこれまで数多くの紫外線
吸収剤が開発されてきたが、現実には効果と安全性、ま
た、化粧品原料としての安定性、溶解性等を兼備したも
のは殆どなかった。
(Problems to be Solved by the Prior Art and Invention) It is known that, in general, sun rays not only cause sunburn but also promote skin aging due to the sunburn. Many ultraviolet absorbers have been developed to prevent the sun rays, but in reality, few of them have the effects and safety as well as the stability and solubility as a cosmetic raw material.

すなわち、我が国で使用前例のある紫外線吸収剤を大
別すると、ベンゾフェノン系、ウロカニン酸系、p−ア
ミノ安息香酸系、ケイ皮酸系、その他(サリチル酸系、
ベンゾトリアゾール系等)に分類されるが、例えばベン
ゾフェノン系は、280〜290nmと320〜330nm付近に吸収極
大を有し汎用されている原料の1つであるが、反面、紅
斑惹起に最も関与する305〜310nm付近の吸収能が相対的
に低いという特性を有している。また、ウロカニン酸系
は生体成分であり安全性も高いが、吸収極大が280〜290
nm付近であるため、特にUV-Aに対しては実用的な効果が
低い。p−アミノ安息香酸系、ケイ皮酸系は、吸収極大
が300〜310nm付近にあり吸収効果も高いが、接触光過敏
症等安全性上に問題があるといわれていた。更に、ベン
ゾトリアゾール系は安全性上から化粧料への配合は控え
られ、また、サリチル酸系は吸収極大が弱く大量に配合
しなければ紫外線防御剤としての機能を保持しがたい欠
点があった。
That is, the ultraviolet absorbers that have precedent use in Japan are roughly classified into benzophenone-based, urocanic acid-based, p-aminobenzoic acid-based, cinnamic acid-based, and other (salicylic acid-based,
For example, benzophenone series is one of the widely used raw materials with absorption maximum around 280 to 290 nm and 320 to 330 nm, but it is most involved in erythema induction. It has a characteristic that the absorption power in the vicinity of 305 to 310 nm is relatively low. In addition, urocanic acid is a biological component and is highly safe, but the maximum absorption is 280 to 290.
Since it is in the vicinity of nm, the practical effect is particularly low for UV-A. The p-aminobenzoic acid type and the cinnamic acid type have maximum absorption around 300 to 310 nm and a high absorption effect, but it is said to have a problem in safety such as contact photosensitivity. Further, the benzotriazole type has a drawback that it is not allowed to be added to cosmetics from the viewpoint of safety, and the salicylic acid type has a weak absorption maximum and has a drawback that it is difficult to retain the function as an ultraviolet protective agent unless a large amount is added.

このような従来の紫外線吸収剤の現状に鑑み、本発明
者等は、種々の素材について探索実験研究を繰り返した
結果、イソフェルラ酸および(または)その塩が紫外線
吸収とチロシナーゼ活性阻害作用を併せもつ有為な特性
を有する物質であることを見出し、これを配合した化粧
料を既に特許出願した(特願昭60-259464(特開昭62-12
0312))。
In view of the current state of such conventional ultraviolet absorbers, the present inventors have repeated exploratory experimental studies on various materials, and as a result, isoferulic acid and / or its salt have both ultraviolet absorption and tyrosinase activity inhibitory action. We have found that the substance has significant properties and have already applied for a patent for a cosmetic composition containing this substance (Japanese Patent Application No. 60-259464 (Japanese Patent Application Laid-Open No. 62-12259).
0312)).

しかしながら、イソフェルラ酸および(または)その
塩は、単独では冷水には難溶(塩では可溶)、アルコー
ル、有機酸および(または)その塩には可溶であるが、
種々の成分が含有される外用基剤中では系との相溶性が
十分でなく、処方系によっては溶解状態で皮膚外用剤に
配合しても比較的短時間のうちに結晶として析出した
り、pHの酸性領域でも結晶が析出してしまうという問題
があった。
However, isoferulic acid and / or its salts are, by themselves, sparingly soluble in cold water (soluble in salts), alcohols, organic acids and / or their salts,
The compatibility with the system is not sufficient in the base for external use containing various components, and depending on the formulation system, it may precipitate as crystals in a relatively short time even if it is added to the skin external preparation in a dissolved state, There is a problem that crystals are precipitated even in the acidic region of pH.

また、pHのアルカリ領域では高温、太陽光で皮膚外用
剤が経時的に変色することもあった。
Further, in the alkaline region of pH, the external preparation for skin may be discolored with time due to high temperature and sunlight.

結晶析出や変色が起こると皮膚外用剤の品質を著しく
損ねることは言うまでもなく、本来の目的の紫外線吸収
能さえも発揮できなくなる状態であった。
Needless to say, the occurrence of crystal precipitation or discoloration significantly impairs the quality of the external preparation for skin, and even the original purpose of absorbing UV light was not achieved.

(問題点を解決する手段) 本発明者は、上記問題点を解決するために鋭意研究し
た結果、皮膚外用基剤中においてイソフェルラ酸および
(または)その塩に対し有機酸および(または)その塩
を併用配合すれば、外用基剤組成、pH領域、太陽光等の
影響を受けず、紫外線吸収効果に優れることは勿論、長
期間品質劣化を起すことの少ない安定性に優れた皮膚外
用剤を得られることを見出し、本発明を完成するに至っ
た。
(Means for Solving the Problems) As a result of intensive studies to solve the above problems, the present inventor has found that organic ferric acid and / or its salt can be used in the skin external base agent against isoferulic acid and / or its salt. When used in combination, it is not affected by the external base composition, pH range, sunlight, etc., and is not only excellent in the effect of absorbing ultraviolet rays, but also a skin external preparation with excellent stability that does not cause long-term quality deterioration. They have found that they can be obtained and have completed the present invention.

すなわち、本発明は優れた紫外線吸収効果ならびに美
白効果、および優れた品質をもつ皮膚外用剤を提供する
ものである。
That is, the present invention provides a skin external preparation having an excellent ultraviolet absorption effect, a whitening effect, and excellent quality.

以下、本発明について詳述する。 Hereinafter, the present invention will be described in detail.

本発明において皮膚外用剤に配合するイソフェルラ酸
および(または)その塩(具体的には水酸化リチウム
塩、水酸化ナトリウム塩、水酸化カリウム塩、水酸化マ
グネシウム塩、水酸化カルシウム塩等の無機塩、アルギ
ニン、リジン、ヒスチジン、オルニチン等のアミノ酸
塩、モノエタノールアミン塩、ジエタノールアミン塩、
トリエタノールアミン塩等の有機塩等)の量は、期待す
る紫外線吸収効果に応じて任意であるが、0.01重量%以
上、特に好ましい量としては0.5重量%以上を選択す
る。しかし、10重量%を越す量を配合しても効果にほと
んど変りは見らず、皮膚外用剤そのものの品質が損なわ
れる。
In the present invention, isoferulic acid and / or its salt to be added to the external preparation for skin (specifically, inorganic salts such as lithium hydroxide salt, sodium hydroxide salt, potassium hydroxide salt, magnesium hydroxide salt, calcium hydroxide salt and the like). , Amino acid salts such as arginine, lysine, histidine, ornithine, monoethanolamine salt, diethanolamine salt,
The amount of an organic salt such as a triethanolamine salt) is arbitrary depending on the expected ultraviolet absorption effect, but is 0.01% by weight or more, and a particularly preferable amount is 0.5% by weight or more. However, even if the amount exceeds 10% by weight, the effect is hardly changed, and the quality of the external preparation for skin itself is impaired.

有機酸および(または)その塩としては、グルコン
酸、コハク酸、シュウ酸、クエン酸、リン酸一水素ナト
リウム、乳酸、酒石酸、酪酸、マロン酸、吉草酸、ギ
酸、酢酸等があげられる。これらの有機酸および(また
は)その塩を1種または2種以上配合するが、本発明の
効果を発揮する目的で配合する量はイソフェルラ酸およ
び(または)その塩の量に対して10〜100%で、かつ、p
Hが6.7〜7.5、好ましくは6.8〜7.2に調整できる量が望
ましい。
Examples of the organic acid and / or its salt include gluconic acid, succinic acid, oxalic acid, citric acid, sodium monohydrogen phosphate, lactic acid, tartaric acid, butyric acid, malonic acid, valeric acid, formic acid and acetic acid. One or more of these organic acids and / or salts thereof are blended, but the amount blended for the purpose of exerting the effect of the present invention is 10 to 100 relative to the amount of isoferulic acid and / or its salt. %, And p
It is desirable that H can be adjusted to 6.7 to 7.5, preferably 6.8 to 7.2.

本発明において、イソフェルラ酸および(または)その
塩と有機酸および(または)その塩とを配合する皮膚外
用基剤としては、通常の皮膚外用基剤であれば、液状、
ゲル状、ペースト状、クリーム状等いずれのものも利用
できる。
In the present invention, as a skin external base for blending isoferuric acid and / or a salt thereof and an organic acid and / or a salt thereof, a normal skin external base is a liquid,
Any of gel, paste, cream and the like can be used.

すなわち、皮膚外用剤を構成する成分としては、保湿
剤、油分、界面活性剤、増粘剤、金属封鎖剤、イソフェ
ルラ酸および(または)その塩以外の紫外線吸収剤、薬
剤、色素、香料等が併用できることは言うまでもない。
That is, as a component constituting the external preparation for skin, a moisturizer, an oil, a surfactant, a thickener, a sequestering agent, an ultraviolet absorber other than isoferulic acid and / or its salt, a drug, a dye, a fragrance, etc. It goes without saying that they can be used together.

(発明の効果) 試料は表1のとおり、本発明にしたがってイソフェル
ラ酸ナトリウムとクエン酸およびリン酸一水素ナトリウ
ムとを配合した皮膚外用剤(実施例1)、実施例1のク
エン酸量を0.2%に変更したもの(比較例1)および実
施例1のクエン酸量を0.01%、リン酸一水素ナトリウム
を0.2%に変更したもの(比較例2)とした。
(Effects of the invention) As shown in Table 1, the samples are the external preparation for skin (Example 1) in which sodium isoferurate is mixed with citric acid and sodium monohydrogen phosphate according to the present invention, and the amount of citric acid in Example 1 is 0.2. % (Comparative example 1) and the citric acid content of example 1 was 0.01%, and sodium monohydrogen phosphate was changed to 0.2% (comparative example 2).

以下配合量は重量部である。 The blending amount below is parts by weight.

表2に保存安定性を示す。 Table 2 shows the storage stability.

次に本発明をより多くの実施例で詳述するが本発明は
これにより限定されるものではない。
The present invention will now be described in more detail with reference to more examples, but the present invention is not limited thereto.

(実施例) 実施例1は前記表1に示したとおりである。実施例2 サンスクリーンクリーム(ゲル状) クエン酸 0.06 リン酸一水素ナトリウム 0.54 γ−トコフェロール 0.02 プロピレングリコール 10.0 イソフェルラ酸ナトリウム 2.0 グリセリン 2.0 エタノール 4.0 ポリオキシエチレン 硬化ヒマシ油(50E0) 1.0 カルボキシビニルポリマー 0.5 苛性カリ 0.15 精製水 79.73(Example) Example 1 is as shown in Table 1 above. Example 2 Sunscreen cream (gel) Citric acid 0.06 Sodium monohydrogen phosphate 0.54 γ-tocopherol 0.02 Propylene glycol 10.0 Sodium isoferurate 2.0 Glycerin 2.0 Ethanol 4.0 Polyoxyethylene hydrogenated castor oil (50E0) 1.0 Carboxyvinyl polymer 0.5 Caustic potash 0.15 Purified water 79.73

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】イソフェルラ酸および(または)その塩と
有機酸および(または)その塩とを配合することを特徴
とする皮膚外用剤。
1. An external skin preparation comprising isoferulic acid and / or a salt thereof and an organic acid and / or a salt thereof.
JP11784087A 1987-05-14 1987-05-14 Topical skin Expired - Lifetime JP2533776B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11784087A JP2533776B2 (en) 1987-05-14 1987-05-14 Topical skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11784087A JP2533776B2 (en) 1987-05-14 1987-05-14 Topical skin

Publications (2)

Publication Number Publication Date
JPS63284119A JPS63284119A (en) 1988-11-21
JP2533776B2 true JP2533776B2 (en) 1996-09-11

Family

ID=14721561

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11784087A Expired - Lifetime JP2533776B2 (en) 1987-05-14 1987-05-14 Topical skin

Country Status (1)

Country Link
JP (1) JP2533776B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9507415D0 (en) * 1994-06-08 1995-05-31 Zylepsis Ltd Production and uses of caffeic acid and derivatives thereof
GB9828380D0 (en) 1998-12-22 1999-02-17 Unilever Plc Skin lightening composition
JP2003292431A (en) * 2002-04-02 2003-10-15 Pola Chem Ind Inc Aerosol cosmetic containing bleaching agent
FR2852828A1 (en) * 2003-03-25 2004-10-01 Oreal COMPOSITION FOR TREATING KERATINIC MATERIALS COMPRISING A HYDROXYCARBOXYLIC ACID AND A PROTECTIVE AGENT OR CONDITIONER
CN117777056A (en) * 2022-09-22 2024-03-29 山东济世药业有限公司 Isoferulic acid piperazine salt and its preparation method, pharmaceutical composition and use

Also Published As

Publication number Publication date
JPS63284119A (en) 1988-11-21

Similar Documents

Publication Publication Date Title
US5788954A (en) Hydrating skin care and sunscreen composition containing dibenzoylmethane derivative, E.G., parsol 1789, and C12, C16, C18 branched chain hydroxybenzoate and/or C12, C16, branched chain benzoate stabilizers/solubilizers
US5849273A (en) Skin care and sunscreen composition containing dibenzoylmethane derivative, e.g., parsol® 1789, and C12, C16, C18 branched chain hydroxybenzoate and/or C12, C16 branched chain benzoate stabilizers/solubilizers
DE2719533C2 (en)
JPH09510969A (en) Artificial tanning composition having improved stability
US4264581A (en) Sunscreen composition
US5208011A (en) Ultraviolet resistant sunscreen compositions
AU5990396A (en) Topical vehicles containing solubilized and stabilized azelaic acid
US3479428A (en) Sunscreen composition and method of using the same
JP2552297B2 (en) Beautiful skin cosmetics
JP2533776B2 (en) Topical skin
JP2564139B2 (en) Topical skin
US3892844A (en) Method of protecting the skin from ultraviolet radiation
JP3625493B2 (en) UV absorbers and external preparations for skin
JP2986966B2 (en) Melanin production inhibitor
JP2552298B2 (en) Beautiful skin cosmetics
KR0163514B1 (en) Whitening Cosmetic Composition
JPH0532531A (en) Cosmetic
JP2533775B2 (en) Topical skin
JPS61215318A (en) External agent for skin
JP2533773B2 (en) Topical skin
JP2533774B2 (en) Topical skin
JPH11199425A (en) Cosmetic
JPS61215311A (en) External agent for skin
JPS61215315A (en) External agent for skin
JPS61215314A (en) External agent for skin